A Three-Part Study Of GSK580416 In Healthy Subjects
NCT00427141
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
48
Enrollment
INDUSTRY
Sponsor class
Conditions
Respiratory Tract Infection
Infections, Bacterial
Interventions
DRUG:
GSK580416
Sponsor
GlaxoSmithKline